IN NEWBORN INFANTS

CSF was obtained from a total of 52 newborn infants by lumbar puncture for diagnostic reasons or post mortem. At the same time a venous blood sample was taken. The infants were divided into two groups: i) "bilirubinemia", including all cases of hyperbilirubi­ nemia and infants presumably without CNS affection (prematurity, RDS, malformations); ii) "CNS affection", including all cases of intracranial hemorrhages and infants suffering from meningitis, sepsis, and congenital toxoplasmosis. Tot~l BR in serum and CSF was determined by standard laboratory methods, CSF-BR was additional­ ly assayed according to van Roy et al.2, with separation of diazo­ tized dipyrroles by thin layer chromatogra?hy. Estimation of BR unbound to albumin (free BR) was performed by the peroxidase tech­ nique3, albumin was estimated by bromocresol green binding4 .

[1]  R. Wennberg,et al.  Determination of unbound bilirubin in the serum of newborns. , 1974, Clinical chemistry.

[2]  K. Kjellin The binding of xanthochromic compounds in the cerebrospinal fluid. Preliminary report. , 1969, Journal of the neurological sciences.

[3]  F. de Meuter,et al.  Determination of bilirubin in liver homogenates and serum with diazotized p-iodoaniline. , 1971, Clinica chimica acta; international journal of clinical chemistry.

[4]  J. Lucey Bilirubin and Brain Damage— A Real Mess , 1982, Pediatrics.